Zhang Guan-hua, Jiang Xiao-bing, Zhang Xiang-heng, Sai Ke, Yang Qun-ying, Chen Zhong-ping, Mou Yong-gao
Department of Neurosurgery, Cancer Center, State Key Laboratory of Oncology in South China, Sun Yat-sen University, Guangzhou 510060, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Jun;27(6):680-2.
To investigate correlation between the expression of TGF-β1 and the amount of Treg cell in glioma, and evaluate their clinical values in predicting the prognosis of glioma.
Double immunohistochemistry staining was used to detect the expression of TGF-β1, CD4 and Foxp3 in 135 specimens of human gliomas (WHO I 18, WHO II 45, WHO III 53, WHO IV 19) and 15 normal brain.
OF the 135 specimans of glioma, 58 showed low TGF-β1 expression and 77 (57.03%) showed high TGF-β1 expression while ws not expression in normal brain tissue. Average Treg cell density in glioma was 2. 031/HP, but there was no expression of Treg in normal brain tissue. Expression of TGF-β1 was positively correlated with the mount of Treg in glioma tissues (r = 0.294, P < 0.01). Compared with the low grade, The levels of TGF-β1 and the amount of Treg cells with significant higher in high-grade glioma, however the mount of Treg had no correlations with Sex, KPS score. The Laplan-Meier analysis showed that there wer significant difference in overall survival (OS) between the TGF-β1 high-expression and low-expression group (P < 0.001). Cox multivariate analysis showed that TGF-β1 and Treg were not independent prognostic factors (P > 0.05).
Intratumoral of TGF-β1 may relate to the infiltration of Treg cells in glioma tissues. The level of TGF-β1 was obviously increased in high grade. Glioma patients with TGF-β1 or Trg high expression have poorer prognosis, while TGF-β1 and Treg cannot serve as independent prognostic factors of glioma survival time.
探讨转化生长因子-β1(TGF-β1)表达与胶质瘤中调节性T细胞(Treg细胞)数量的相关性,并评估其在预测胶质瘤预后中的临床价值。
采用双重免疫组化染色法检测135例人脑胶质瘤标本(世界卫生组织(WHO)I级18例、WHO II级45例、WHO III级53例、WHO IV级19例)及15例正常脑组织中TGF-β1、CD4和叉头框蛋白3(Foxp3)的表达。
135例胶质瘤标本中,58例TGF-β1表达低,77例(57.03%)TGF-β1表达高,正常脑组织中无表达。胶质瘤中Treg细胞平均密度为2.031/高倍视野(HP),正常脑组织中无Treg细胞表达。胶质瘤组织中TGF-β1表达与Treg细胞数量呈正相关(r = 0.294,P < 0.01)。与低级别胶质瘤相比,高级别胶质瘤中TGF-β1水平及Treg细胞数量显著更高,然而Treg细胞数量与性别、卡氏评分(KPS)无关。寿命表分析显示,TGF-β1高表达组与低表达组的总生存期(OS)有显著差异(P < 0.001)。Cox多因素分析显示,TGF-β1和Treg不是独立的预后因素(P > 0.05)。
胶质瘤组织中TGF-β1可能与Treg细胞浸润有关。高级别胶质瘤中TGF-β1水平明显升高。TGF-β1或Treg高表达的胶质瘤患者预后较差,而TGF-β1和Treg不能作为胶质瘤生存时间的独立预后因素。